---
category: news
title: "Iktos and Facio Therapies Announce Collaboration to Use AI for FSHD Drug Design"
excerpt: "Iktos, a company specialized in Artificial Intelligence for new drug design, and Facio Therapies, a drug discovery and development company focused on developing treatments for facioscapulohumeral dystrophy (FSHD),"
publishedDateTime: 2021-05-11T10:00:00Z
originalUrl: "https://www.businesswire.com/news/home/20210510006014/en/Iktos-and-Facio-Therapies-Announce-Collaboration-to-Use-AI-for-FSHD-Drug-Design"
webUrl: "https://www.businesswire.com/news/home/20210510006014/en/Iktos-and-Facio-Therapies-Announce-Collaboration-to-Use-AI-for-FSHD-Drug-Design"
type: article
quality: 15
heat: 15
published: false

provider:
  name: Business Wire
  domain: businesswire.com

topics:
  - AI in Healthcare
  - AI

secured: "F3/NlgwjHzjoaXjFxm4QER88+XdB+A/NIF23OtmGBRlzn0Nl4C77RTDitFI5gogRkPDUJbzjBBq38smHZTyVyax0j76VMwi8+k2erT8/bWCoSY/OQBowgx+zGJY+NVYHLT3vByFn5fcFonYjjWMgb7cSgUaB9nn+qA1RGoGI+tiZOEFZ700lAzK7BRom0H7iKG2WDYMnwZszOS5Mu/TUa3jyOPcxZ01ecoUN1Sp8IUH+KWtkG9jE//WhhIzqv9AUmE3yYLC8UUzq554Wr/gU4e2chu4xIdlWt5hJnhkiLAVxZNq0GcOSUkZLOIgcozZCb/xVr4zO17BPhoZM7tVGcXp4o5coYkMjUyUtcZjAUGA=;qc2uGyDXbS7vgRZys2EvnA=="
---

